A randomised trial of Myfortic versus mycophenolate in the treatment of multisystem autoimmune disease

Trial Profile

A randomised trial of Myfortic versus mycophenolate in the treatment of multisystem autoimmune disease

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2016

At a glance

  • Drugs Mycophenolate sodium (Primary) ; Mycophenolate mofetil
  • Indications Systemic lupus erythematosus; Systemic vasculitis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MYFMAD
  • Most Recent Events

    • 19 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top